Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Nodular Lesions on the Upper Trunk: An Uncommon Anatomical Site of Renal Tumor Metastases.

Kostopoulos N, Platsidaki E, Tzanetakou V, Petraki K, Lekarakou M, Bafaloukos D, Potouridou I.

Indian J Dermatol. 2019 May-Jun;64(3):251. doi: 10.4103/ijd.IJD_634_16.

2.

Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer.

Rallis G, Koletsa T, Saridaki Z, Manousou K, Koliou GA, Kostopoulos I, Kotoula V, Makatsoris T, Kourea HP, Raptou G, Chrisafi S, Samantas E, Papaparaskeva K, Pazarli E, Papakostas P, Kafiri G, Mauri D, Papoudou-Bai A, Christodoulou C, Petraki K, Dombros N, Pectasides D, Fountzilas G.

Anticancer Res. 2019 Apr;39(4):2129-2138. doi: 10.21873/anticanres.13326.

PMID:
30952759
3.

Central nervous system tuberculosis reactivation following intravenous iron supplementation.

Karakonstantis S, Emmanouilidou E, Petraki K, Lydakis C.

Int J Mycobacteriol. 2019 Jan-Mar;8(1):104-106. doi: 10.4103/ijmy.ijmy_10_19.

4.

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

Koutras A, Lazaridis G, Koliou GA, Kouvatseas G, Christodoulou C, Pectasides D, Kotoula V, Batistatou A, Bobos M, Tsolaki E, Papadopoulou K, Pentheroudakis G, Papakostas P, Pervana S, Petraki K, Chrisafi S, Razis E, Psyrri A, Bafaloukos D, Kalogeras KT, Kalofonos HP, Fountzilas G.

PLoS One. 2018 Dec 6;13(12):e0207707. doi: 10.1371/journal.pone.0207707. eCollection 2018.

5.

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials.

Batistatou A, Kotoula V, Bobos M, Kouvatseas G, Zagouri F, Tsolaki E, Gogas H, Koutras A, Pentheroudakis G, Timotheadou E, Pervana S, Goussia A, Petraki K, Sotiropoulou M, Koletsa T, Razis E, Kosmidis P, Aravantinos G, Papadimitriou C, Pectasides D, Fountzilas G.

Clin Breast Cancer. 2018 Feb;18(1):53-62.e3. doi: 10.1016/j.clbc.2017.07.004. Epub 2017 Jul 13.

PMID:
28870680
6.

The Prognostic Value of the Immunohistochemical Expression of Phosphorylated RB and p16 Proteins in Association with Cyclin D1 and the p53 Pathway in a Large Cohort of Patients with Breast Cancer Treated with Taxane-based Adjuvant Chemotherapy.

Gavressea T, Kalogeras KT, Koliou GA, Zagouri F, Lazaridis G, Gogas H, Tsigaridas K, Koutras A, Petraki K, Markopoulos C, Pazarli E, Aravantinos G, Papadimitriou C, Papakostas P, Koufopoulos N, Karanikiotis C, Chrisafi S, Kalofonos HP, Pectasides D, Fountzilas G, Pavlakis K.

Anticancer Res. 2017 Jun;37(6):2947-2957.

PMID:
28551632
7.

Acute Pancreatitis Following Endoscopic Ampullary Biopsies without Attempted Cannulation of the Ampulla of Vater.

Michopoulos S, Kozompoli D, Ntai S, Kalantzis G, Zampeli E, Petraki K.

Clin Endosc. 2016 Nov;49(6):575-578. Epub 2016 Jul 20.

8.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer.

Gogas H, Kotoula V, Alexopoulou Z, Christodoulou C, Kostopoulos I, Bobos M, Raptou G, Charalambous E, Tsolaki E, Xanthakis I, Pentheroudakis G, Koutras A, Bafaloukos D, Papakostas P, Aravantinos G, Psyrri A, Petraki K, Kalogeras KT, Pectasides D, Fountzilas G.

J Transl Med. 2016 May 17;14(1):136. doi: 10.1186/s12967-016-0883-z.

9.

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.

Georgopoulos SD, Xirouchakis E, Martinez-Gonzales B, Zampeli E, Grivas E, Spiliadi C, Sotiropoulou M, Petraki K, Zografos K, Laoudi F, Sgouras D, Mentis A, Kasapidis P, Michopoulos S.

Eur J Intern Med. 2016 Jul;32:84-90. doi: 10.1016/j.ejim.2016.04.011. Epub 2016 Apr 28.

PMID:
27134145
10.

Hormonal receptor status, Ki-67 and HER2 expression: Prognostic value in the recurrence of ductal carcinoma in situ of the breast?

Poulakaki N, Makris GM, Battista MJ, Böhm D, Petraki K, Bafaloukos D, Sergentanis TN, Siristatidis C, Chrelias C, Papantoniou N.

Breast. 2016 Feb;25:57-61. doi: 10.1016/j.breast.2015.10.007. Epub 2015 Nov 21.

PMID:
26612082
11.

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

Linardou H, Kalogeras KT, Kronenwett R, Alexopoulou Z, Wirtz RM, Zagouri F, Scopa CD, Gogas H, Petraki K, Christodoulou C, Pavlakis K, Koutras AK, Samantas E, Patsea H, Pectasides D, Bafaloukos D, Fountzilas G.

Anticancer Res. 2015 Jul;35(7):4023-36.

PMID:
26124351
12.

PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.

Koumarianou A, Karayannopoulou G, Gourgioti G, Batistatou A, Bobos M, Efstratiou I, Miliaras D, Galani E, Pentheroudakis G, Pectasides D, Aravantinos G, Bafaloukos D, Papakostas P, Razis E, Kalofonos HP, Petraki K, Sotiropoulou M, Kalogeras KT, Fountzilas G.

Cancer Chemother Pharmacol. 2015 Jun;75(6):1289-301. doi: 10.1007/s00280-015-2762-3. Epub 2015 May 7.

PMID:
25947084
13.

Emerging role of linker histone variant H1x as a biomarker with prognostic value in astrocytic gliomas. A multivariate analysis including trimethylation of H3K9 and H4K20.

Sepsa A, Levidou G, Gargalionis A, Adamopoulos C, Spyropoulou A, Dalagiorgou G, Thymara I, Boviatsis E, Themistocleous MS, Petraki K, Vrettakos G, Samaras V, Zisakis A, Patsouris E, Piperi C, Korkolopoulou P.

PLoS One. 2015 Jan 20;10(1):e0115101. doi: 10.1371/journal.pone.0115101. eCollection 2015.

14.

Particle-antiparticle asymmetries from annihilations.

Baldes I, Bell NF, Petraki K, Volkas RR.

Phys Rev Lett. 2014 Oct 31;113(18):181601. Epub 2014 Oct 30.

PMID:
25396359
15.

Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.

El-Habr EA, Levidou G, Trigka EA, Sakalidou J, Piperi C, Chatziandreou I, Spyropoulou A, Soldatos R, Tomara G, Petraki K, Samaras V, Zisakis A, Varsos V, Vrettakos G, Boviatsis E, Patsouris E, Saetta AA, Korkolopoulou P.

Virchows Arch. 2014 Oct;465(4):473-85. doi: 10.1007/s00428-014-1641-3. Epub 2014 Aug 22.

PMID:
25146167
16.

Detection of TMPRSS2-ERG fusion gene in benign prostatic hyperplasia.

Velaeti S, Dimitriadis E, Kontogianni-Katsarou K, Savvani A, Sdrolia E, Pantazi G, Stefanakis S, Trangas T, Pandis N, Petraki K.

Tumour Biol. 2014 Oct;35(10):9597-602. doi: 10.1007/s13277-014-2250-0. Epub 2014 Jun 25.

PMID:
24961351
17.

From the lymph nodes to the muscles: an unusual case of refractory familial Mediterranean classic Kaposi sarcoma.

Ioannidou M, Panayiotakopoulos G, Skarlos D, Petraki K, Doulas N, Mileounis K, Christodoulou C.

Int J Dermatol. 2016 Oct;55(10):1143-5. doi: 10.1111/ijd.12497. Epub 2014 Apr 16. No abstract available.

PMID:
24739057
18.

Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.

Korkolopoulou P, Levidou G, El-Habr EA, Adamopoulos C, Fragkou P, Boviatsis E, Themistocleous MS, Petraki K, Vrettakos G, Sakalidou M, Samaras V, Zisakis A, Saetta A, Chatziandreou I, Patsouris E, Piperi C.

Br J Cancer. 2013 May 28;108(10):2142-52. doi: 10.1038/bjc.2013.176. Epub 2013 Apr 25.

19.
20.

Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets.

Tournis S, Georgoulas T, Zafeiris C, Papalexis C, Petraki K, Lyritis GP.

J Musculoskelet Neuronal Interact. 2011 Sep;11(3):266-9. No abstract available.

21.

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.

Fountzilas G, Kourea HP, Bobos M, Televantou D, Kotoula V, Papadimitriou C, Papazisis KT, Timotheadou E, Efstratiou I, Koutras A, Pentheroudakis G, Christodoulou C, Aravantinos G, Miliaras D, Petraki K, Papandreou CN, Papakostas P, Bafaloukos D, Repana D, Razis E, Pectasides D, Dimopoulos AM.

Anticancer Res. 2011 Sep;31(9):3007-18. Erratum in: Anticancer Res. 2011 Oct;31(10):3637. Dosage error in article text.

PMID:
21868552
22.

Prognostic significance of IL-8-STAT-3 pathway in astrocytomas: correlation with IL-6, VEGF and microvessel morphometry.

Piperi C, Samaras V, Levidou G, Kavantzas N, Boviatsis E, Petraki K, Grivas A, Barbatis C, Varsos V, Patsouris E, Korkolopoulou P.

Cytokine. 2011 Sep;55(3):387-95. doi: 10.1016/j.cyto.2011.05.012.

PMID:
21684758
23.

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

Razis E, Bobos M, Kotoula V, Eleftheraki AG, Kalofonos HP, Pavlakis K, Papakostas P, Aravantinos G, Rigakos G, Efstratiou I, Petraki K, Bafaloukos D, Kostopoulos I, Pectasides D, Kalogeras KT, Skarlos D, Fountzilas G.

Breast Cancer Res Treat. 2011 Jul;128(2):447-56. doi: 10.1007/s10549-011-1572-5. Epub 2011 May 19.

PMID:
21594665
24.

Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.

Cholongitas E, Papatheodoridis GV, Manesis EK, Petraki K, Tiniakos D, Hadziyannis SJ.

J Med Virol. 2011 Jul;83(7):1165-71. doi: 10.1002/jmv.21780.

PMID:
21567420
25.

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.

Gogas H, Pectasides D, Kostopoulos I, Lianos E, Skarlos D, Papaxoinis G, Bobos M, Kalofonos HP, Petraki K, Pavlakis K, Bafaloukos D, Fountzilas G.

Clin Breast Cancer. 2010 Jun;10(3):230-7. doi: 10.3816/CBC.2010.n.031.

PMID:
20497922
26.

CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.

Panayotopoulou EG, Sgouras DN, Papadakos KS, Petraki K, Breurec S, Michopoulos S, Mantzaris G, Papatheodoridis G, Mentis A, Archimandritis A.

J Clin Microbiol. 2010 Jun;48(6):2237-9. doi: 10.1128/JCM.00662-10. Epub 2010 Apr 14.

27.

A pilot study comparing hydrocortisone premedication to concomitant azathioprine treatment in preventing loss of response to infliximab.

Mantzaris GJ, Viazis N, Petraki K, Papamichael K, Theodoropoulos I, Roussos A, Karakoidas C, Koilakou S, Raptis N, Smyrnidis A, Agalos G, Karamanolis DG.

Eur J Gastroenterol Hepatol. 2009 Sep;21(9):1042-8. doi: 10.1097/MEG.0b013e32832937e3.

PMID:
20139856
28.

Small cell carcinoma of the urinary tract: a case report.

Kozyrakis D, Papadaniil P, Stefanakis S, Pantazis E, Grigorakis A, Petraki K, Malovrouvas D.

Cases J. 2009 Jul 24;2:7743. doi: 10.4076/1757-1626-2-7743.

29.

In vitro and in vivo safety evaluation of the bacteriocin producer Streptococcus macedonicus ACA-DC 198.

Maragkoudakis PA, Papadelli M, Georgalaki M, Panayotopoulou EG, Martinez-Gonzalez B, Mentis AF, Petraki K, Sgouras DN, Tsakalidou E.

Int J Food Microbiol. 2009 Jul 31;133(1-2):141-7. doi: 10.1016/j.ijfoodmicro.2009.05.012. Epub 2009 May 15.

PMID:
19515446
30.

Renal actinomycosis presenting as a suppurated solitary cyst.

Efthimiou I, Mamoulakis C, Petraki K, Zorzos I.

Indian J Urol. 2008 Jul;24(3):416-8. doi: 10.4103/0970-1591.42631.

31.

Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma.

Türe-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, Petraki K, Giannakopoulos A, Korkolopoulou P, Mantzaris GJ.

Anticancer Res. 2008 Nov-Dec;28(6A):3697-700.

32.

Patients with duodenal ulcer have lower levels of serum cholesterol compared to other dyspeptic patients independently of Helicobacter pylori status.

Karpouza A, Samouilidou E, Karagiannis S, Kostopoulou V, Sotiropoulou M, Roma E, Petraki K, Michopoulos S.

Scand J Gastroenterol. 2008 Aug;43(8):922-8.

PMID:
19086276
33.

Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.

Mantzaris GJ, Christidou A, Sfakianakis M, Roussos A, Koilakou S, Petraki K, Polyzou P.

Inflamm Bowel Dis. 2009 Mar;15(3):375-82. doi: 10.1002/ibd.20777.

PMID:
19009634
34.

Response of malignant thymoma to erlotinib.

Christodoulou C, Murray S, Dahabreh J, Petraki K, Nikolakopoulou A, Mavri A, Skarlos D.

Ann Oncol. 2008 Jul;19(7):1361-2. doi: 10.1093/annonc/mdn388. Epub 2008 Jun 4. No abstract available.

PMID:
18534960
35.

Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract.

Michopoulos S, Petraki K, Matsouka C, Kastritis E, Chrysanthopoulou H, Dimopoulos MA.

J Clin Oncol. 2008 Mar 20;26(9):1555-7. doi: 10.1200/JCO.2007.14.9856. No abstract available.

PMID:
18349408
36.

Total and free PSA kinetics in patients without prostate cancer undergoing radical cystoprostatectomy.

Gregorakis AK, Stefanakis S, Malovrouvas D, Petraki K, Gourgiotis D, Scorilas A.

Prostate. 2008 May 15;68(7):759-65. doi: 10.1002/pros.20733.

PMID:
18213630
37.

The long-term efficacy of azathioprine does not wane after four years of continuous treatment in patients with steroid-dependent luminal Crohn's disease.

Mantzaris GJ, Roussos A, Christidou A, Koilakou S, Kalantzis CN, Petraki K, Sfakianakis M, Karagiannidis A, Polyzou P.

J Crohns Colitis. 2007 Sep;1(1):28-34. doi: 10.1016/j.crohns.2007.06.002.

PMID:
21172181
38.

Primitive neurectodermal tumors: a case of extraosseous Ewing's sarcoma of the small intestine and review of the literature.

Batziou C, Stathopoulos GP, Petraki K, Papadimitriou C, Rigatos SK, Kondopodis E, Stathopoulos J, Batzios S.

J BUON. 2006 Oct-Dec;11(4):519-22.

39.

Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Chrysanthos N, Kafiri G, Petraki K, Hadziyannis E, Pandelidaki H, Zafiropoulou R, Savvas S, Koskinas J, Archimandritis AJ.

Am J Gastroenterol. 2007 Mar;102(3):634-41.

PMID:
17222326
40.

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.

Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D, Skaltsounis AL.

Antimicrob Agents Chemother. 2007 Feb;51(2):551-9. Epub 2006 Nov 20.

41.

Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.

Papatheodoridis GV, Chrysanthos N, Savvas S, Sevastianos V, Kafiri G, Petraki K, Manesis EK.

J Viral Hepat. 2006 May;13(5):303-10.

PMID:
16637860
42.

Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis.

Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, Archimandritis AJ.

Eur J Gastroenterol Hepatol. 2006 Apr;18(4):389-96.

PMID:
16538110
43.

Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A.

Clin Diagn Lab Immunol. 2005 Dec;12(12):1378-86.

44.

Prostate cancer with small-cell morphology: an immunophenotypic subdivision.

Petraki C, Vaslamatzis M, Petraki K, Revelos K, Alevizopoulos N, Papanastasiou P, Gregorakis A.

Scand J Urol Nephrol. 2005;39(6):455-63.

PMID:
16303720
45.

Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.

Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.

J Viral Hepat. 2005 Nov;12(6):635-41.

PMID:
16255765
46.

Prevalence of celiac disease in patients with Crohn's disease.

Mantzaris GJ, Roussos A, Koilakou S, Petraki K, Rontogianni D, Tsirogianni A, Triantafyllou G.

Inflamm Bowel Dis. 2005 Nov;11(11):1029. No abstract available.

PMID:
16239853
47.

Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.

Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM.

Am J Physiol Endocrinol Metab. 2006 Mar;290(3):E550-9. Epub 2005 Oct 11.

48.

Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.

Gregorakis AK, Malovrouvas D, Stefanakis S, Petraki K, Scorilas A.

Clin Chim Acta. 2005 Jul 24;357(2):196-201.

PMID:
15936010
49.

Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B.

Papatheodoridis GV, Petraki K, Cholongitas E, Kanta E, Ketikoglou I, Manesis EK.

J Viral Hepat. 2005 Mar;12(2):199-206. Erratum in: J Viral Hepat. 2005 Jul;12(4):443.

PMID:
15720536
50.

A 23-year-old woman with complete paraplegia and anesthesia below the T8 level.

Themistocleous GS, Papagelopoulos PJ, Petraki KD, Stilianessi EV, Partsinevelos AA, Sapkas GS.

Clin Orthop Relat Res. 2005 Jan;(430):258-65. No abstract available.

PMID:
15662333

Supplemental Content

Loading ...
Support Center